Navigation Links
Article Now Available: Are Special Orders Draining Your Budgets?
Date:8/5/2009

CARY, N.C., Aug. 5 /PRNewswire/ -- SciQuest, Inc., the global leader empowering enterprises to realize the potential of strategic procurement, today announced the availability of the first article in the company's Procurement Insight Series for the healthcare industry. The article, "Are Specials Draining Your Budgets? Learn how to Plug the Leaks," details how special orders can harm productivity and profitability while offering solutions to help organizations get to the source of the problem and remove costs throughout the purchasing process.

"In this economic environment, finance and supply chain professionals in healthcare organizations are under increased pressure to cut costs and drive on-contract spending," said Krista Fuller, director of Product Marketing for Healthcare at SciQuest. "One critical component of supply costs includes special orders, which are manual workarounds when staff cannot find the right product in the ERP item master file. Special orders are typically purchased at retail or non-contracted prices and, therefore, are a leading contributor to the erosion of hospital profits. With the right solutions in place, healthcare organizations can save an average of 8 percent through the reduction of special orders."

Content, or lack of it, in the ERP item master file is at the heart of why most special orders are placed. "Are Specials Draining Your Budgets?" details the productivity and profitability losses generated by special orders, such as overpayments and invoicing errors, and provides best practice guidance from the results one organization found with a content management solution, including a 33 percent reduction in the number of special items purchased and 20 percent savings on ea
'/>"/>

SOURCE SciQuest, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. New DeKaye Article Identifies Hierarchy of Greed in Healthcare Fraud
2. Nanoparticle-delivered 'Suicide' Genes Slowed Ovarian Tumor Growth
3. AlphaRx Presents Positive Preclinical Data on Zysolin(TM) Inhalable Nanoparticles at Controlled Release Society Annual Meeting
4. Team24 News Article - New EU Directive Offers a Healthy Outlook for Niche Recruitment Companies like Team24
5. Physician Hospitals (PHA) Responds to TIME Magazine Article: Filled With Incorrect Assumption and Innuendo
6. Eliminating polio requires global, coordinated effort -- Health Affairs article highlights risks, rewards of eradication
7. Crestor Patent Invalidity Evidence Uncovered By Article One Partners Community
8. Articles by Prominent Scientists Featured in 25th Anniversary Issue
9. AACE Response to Insulin Glargine Cancer Risk Articles in Diabetologia
10. Making nanoparticles in artificial cells
11. Hospice of Michigan President and CEO Available for Comment on New England Journal of Medicine Article on Profits in Hospice Industry and Proposed Changes From MedPAC

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...t their response to a "cocaine-cues" video, active...s activity in brain regions linked to drug craving...of Energy,s Brookhaven National Laboratory. The re...uroImage , suggest that clinical interventions des...ld help cocaine abusers stop using drugs and avoid...
(Date:11/30/2009)...nd dessert at the holiday table are even less of a...ccording to a new research report recently appeari...bj.org ), a diet that is high in fat and in sugar ...ur bodies to store too much fat. This means these ...difficult task of converting high-fat and high-sug...
(Date:11/30/2009)...avily more often than younger people, study finds,...- Older people who are problem drinkers consume mo...report finds, possibly because they need more alco... a study released this month, people dependent on ... drinks a week, on average. By contrast, younger a...
(Date:11/30/2009).... Rappa, MD, explores the intricate connection bet...ealing Heart to Soul: One Doctor’s Journey o...9). , Dallas, TX (Vocus) ... let go of negative emotions, whether caused by us...oulders. Oftentimes, this disease of the human spi...
(Date:11/30/2009)..., Nov. 30 Baxa Corporation is spon... "culture of safety" means in today,s pharmacy env...eating a Culture of Safety in Pharmacy ," features... their experiences with culture of safety, what it...d the role of technology in enabling or inhibiting...
Breaking Medicine News(10 mins):Health News:Brain scan study shows cocaine abusers can control cravings 2Health News:Brain scan study shows cocaine abusers can control cravings 3Health News:Western diets turn on fat genes 2Health News:Binge Drinking Not Just a Rite of the Young 2Health News:Healing from the Inside Out: Compelling New Book Explores the Intricate Connection between Body, Soul, and Better Health 2Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 2Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 3
..., Rockville, Md., September 24, 2008 The U.S. Ph...e the release of its first Certified Reference Mat...cently became the first global pharmacopeia to rec... with a new class of reference standard that ensur...
..., The depth of transmural tumor invasion along th...al lymph nodes constitute major factors in the pro...rative staging of rectal cancer carries a crucial ...rated well in the literature. However, studies com...
..., Black Americans have a higher occurrence of col...nificant finding considering the incidence of colo...d unchanged among black women during the last 20 y...d A. Lieberman, M.D., head of gastroenterology, Or...
...Pioneer of concierge medicine selects finest local...cago practice, BELLEVUE, Wash., Sept. 24 MD2 Int...ned a Chicago practice with two of the,area,s fine...hysicians and expand its network., "Many of the f...
...Panel of ALS Researchers to Present and Consider t...., Sept. 24 The ALS Therapy,Development Institute...annual ALS research symposium, part of the fourth ...cientists will provide,presentations on the develo...
...Deal Marks First High-Definition Interactive Syste...thcare Facility Deployment, SIOUX FALLS, S.D., Se...t Interactive Corporation (Nasdaq: LNET ),announc...sity HealthSystem facilities in the Chicago area. ...
Other Medicine News:Health News:Which is more accurate on diagnosis of rectal carcinoma? 2Health News:Black Americans are at higher risk for colon polyps 2Health News:MD2 International Brings Highly Attentive Medicine to Chicago 2Health News:ALS Patients and Researchers Unite in Boston for 4th Annual Leadership Summit 2Health News:ALS Patients and Researchers Unite in Boston for 4th Annual Leadership Summit 3Health News:ALS Patients and Researchers Unite in Boston for 4th Annual Leadership Summit 4Health News:LodgeNet Healthcare Signs New Agreement with NorthShore University HealthSystem 2Health News:LodgeNet Healthcare Signs New Agreement with NorthShore University HealthSystem 3
(Date:11/30/2009)... , , INDIANAPOLIS, Nov. 30 /PRNew...tration (FDA) has approved Cymbalta® (duloxet...zed anxiety disorder (GAD) in adults, Eli Lilly an...ince generalized anxiety disorder can be a chronic...atients find a treatment option that is effective ...
(Date:11/30/2009)... , , THOUSAND OAKS, Calif., Nov. 30 /PR... today announced that it will present updated long...omiplostim) in adult chronic immune (idiopathic) t... will present the first Nplate study in a pediatri...tic syndromes (MDS) at the 2009 American Society o...
(Date:11/29/2009)... , , CHICAGO, Nov. 30 Rad...is from a remote location with the use of a handhe...ftware, according to a study presented today at th...rth America (RSNA). ,, "The goal is to improve...ell as to improve communications among different c...
Breaking Medicine Technology:FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 2FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 3FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 4FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 5Amgen Highlights Data to be Presented at ASH 2Amgen Highlights Data to be Presented at ASH 3Amgen Highlights Data to be Presented at ASH 4Amgen Highlights Data to be Presented at ASH 5Amgen Highlights Data to be Presented at ASH 6Amgen Highlights Data to be Presented at ASH 7Amgen Highlights Data to be Presented at ASH 8Amgen Highlights Data to be Presented at ASH 9Amgen Highlights Data to be Presented at ASH 10Amgen Highlights Data to be Presented at ASH 11Smart Phones Allow Quick Diagnosis of Acute Appendicitis 2Smart Phones Allow Quick Diagnosis of Acute Appendicitis 3LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 1LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 2LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 3LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 4SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 1SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 2SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 3SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 4SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 5PDL BioPharma Elects Barry Selick to Its Board of Directors 53479 1PDL BioPharma Elects Barry Selick to Its Board of Directors 53479 2
..., Fla. , May 29 GlaxoSmithKline [NYSE: GSK] and ...ted States Food and Drug Administration,s (FDA) On...o three that the ARZERRA(TM) (ofatumumab) data are... patients with chronic lymphocytic leukemia (CLL) ...mtuzumab. Ofatumumab is an investigational treatme...
...VILLE, Pa., May 29 Wyeth Pharmaceuticals, a divis...minary data from two ongoing studies, one evaluati...umab (Herceptin(R), Roche) in HER-2 positive (ErbB...nvestigating neratinib safety and efficacy when gi...b) in patients with HER-2 dependent solid tumors. ...
Other Medicine Technology:FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab) 2FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab) 3FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab) 4FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab) 5New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer 2New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer 3New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer 4New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer 5
7121B Sony Medical Monitor
...ompletely new and revolutionary lens system. The u... size without distortion. The 115 field of view su...tion of the telescope. Beyond that a new quick loc... is introduced. It is the combination of outstandi...
...e the surgeon with an optimal work area and reduce...t and retinal surgery. Perfect Pupil Injectable is...pils which allows expansion of the pupil to 8mm co...gery, and allows the pupil to return to its normal...
Defiant 95% Bag Filter
Medicine Products: